Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Article too big to display. Click here to view on the SEC website

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Wave Life Sciences Charts.

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Wave Life Sciences Charts.

Wave Life Sciences Ltd News

Form 4 - Statement of changes in beneficial ownership of securities
Saturday 8 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Saturday 8 March 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 6 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Wave Life Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Tuesday 4 March 2025 (6 days ago) • GlobeNewswire Inc.

Wave Life Sciences Fourth Quarter and Full Year 2024 Financial Results Scheduled for March 4, 2025
Wednesday 26 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 7 February 2025 (1 month ago) • Edgar (US Regulatory)

Wave Life Sciences Announces Initiation of Phase 1 INLIGHT Clinical Trial of WVE-007 in Obesity
Friday 7 February 2025 (1 month ago) • GlobeNewswire Inc.

More Wave Life Sciences Ltd News Articles

Australian SE All Ordina...

Australia And New Zealan...

Commonwealth Bank Of Aus...

Verizon Communications

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions